Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation-Reference-Cited by-同舟云学术

Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

Published:2020-03 Issue:3 Volume:26 Page:451-457
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Carré Martin,Porcher Raphaël^ORCID,Finke Jürgen,Ehninger Gerhard,Koster Linda,Beelen Dietrich,Ganser Arnold,Volin Liisa,Lozano Sara,Friis Lone,Michallet Mauricette,Tischer Johanna,Olavarria Eduardo,Cascon Maria Jesús Pascual,Iacobelli Simona,Koc Yener^ORCID,Jindra Pavel^ORCID,Arat Mutlu,de Witte Theo,Yakoub Agha Ibrahim,Kröger Nicolaus,Robin Marie

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference42 articles.

1. Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population;Maynadié;Br J Cancer,1996

2. No increase in age-specific incidence of myelodysplastic syndromes;Germing;Haematologica,2004

3. Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDS-registry;Neukirchen;Leuk Res,2011

4. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

5. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study;Fenaux;Lancet Oncol,2009

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee;Blood;2024-05-30

2. Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: a nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular Therapy;Bone Marrow Transplantation;2024-05-07

3. Advances in the management of higher-risk myelodysplastic syndromes: future prospects;Leukemia & Lymphoma;2024-05-07

4. Pretransplantation Inflammatory and Nutritional Status in Elderly Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Value of C-Reactive Protein-to-Albumin Ratio;Transplantation and Cellular Therapy;2024-04

5. Validation of the Molecular International Prognostic Scoring System (IPSS-M) for myelodysplastic neoplasms (MDS) and comparison with the revised International Prognostic Scoring System (IPSS-R) in Chinese Population: A Multicenter Retrospective Study.;2024-03-25